Showing results (261-270 of 411) with videos related to

Sort By:
Pageof 42
Proteomics|November 10, 2018
UFLC-Derived CSF Extracellular Vesicle Origin and ProteomeAlexander G Thompson, Elizabeth Gray, Imre Mager, et al.
Brain Communications|July 3, 2020
Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosisGreig Joilin, Elizabeth Gray, Alexander G Thompson, et al.
Brain Communications|May 23, 2024
The cortical neurophysiological signature of amyotrophic lateral sclerosisMichael Trubshaw, Chetan Gohil, Katie Yoganathan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 26, 2023
ALSUntangled #71: NuedextaYuyao Sun, Michael Benatar, Javier Mascías Cadavid, et al.
Neuroimage. Clinical|June 18, 2024
Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging studyHans-Peter Müller, Agessandro Abrahao, Christian Beaulieu, et al.
The Lancet. Neurology|June 23, 2023
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Michael Benatar, Metin Kurtoglu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 18, 2015
Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosisLisa A van der Kleij, Ashley R Jones, I Nick Steen, et al.
BMC Neuroscience|March 14, 2018
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathologyMenuka Pallebage-Gamarallage, Sean Foxley, Ricarda A L Menke, et al.
Neurology. Genetics|June 22, 2023
Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in AfricansNomakhosazana R Monnakgotla, Amokelani C Mahungu, Jeannine M Heckmann, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 22, 2018
Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case reportCyril Pottier, Evadnie Rampersaud, Matt Baker, et al.
Pageof 42